Pharmabiz51m
EU CHMP recommends approval of Merck’s Keytruda regimens as treatment for patients with two types of gynaecologic cancers
EU CHMP recommends approval of Merck’s Keytruda regimens as treatment for patients with two types of gynaecologic cancers ...
Pharmabiz1h
FIPO Kerala chapter to celebrate WPD on September 25 in Thiruvananthapuram
World Pharmacist Day, the largest global platform for pharmacy public outreach, will be celebrated in Kerala this year under the leadership of the state unit of the Federation of Indian Pharmacists ...
Pharmabiz1h
Industry adopting pragmatic approach to UCPMP to ensure a more ethical & transparent marketing environment
The Indian pharmaceutical industry is adopting a pragmatic approach to the Uniform Code of Pharmaceutical Marketing Practices (UCPMP), which will be instrumental in ensuring a smooth transition to a ...
Pharmabiz1h
Pharmaceuticals exports report 4.7 per cent growth in August
Exports of drugs and pharmaceuticals from the country registered a growth of 4.67 per cent growth, even as the imports reported a decline of 2.64 per cent during the month of August. The sector ...
Pharmabiz1h
EMA committee recommends marketing approval for AbbVie’s mirvetuximab soravtansine for the treatment of certain adult ovarian cancer
North Chicago, Illinois Monday, September 23, 2024, 13:00 Hrs [IST] ...
Pharmabiz2h
Samsung Bioepis, Biogen receive positive CHMP opinion for aflibercept biosimilar, Opuviz
Samsung Bioepis, Biogen receive positive CHMP opinion for aflibercept biosimilar, Opuviz: Incheon, Korea Monday, September 23, 2024, 12:00 Hrs [IST] Samsung Bioepis Co., Ltd., a b ...
Pharmabiz3h
EMA committee recommends approval of Sanofi & Regeneron’s Dupixent to treat eosinophilic esophagitis in children as young as 1 year old
EMA committee recommends approval of Sanofi & Regeneron’s Dupixent to treat eosinophilic esophagitis in children as young as 1 year old: Paris Monday, September 23, 2024, 11:00 ...
Pharmabiz4h
EMA’s human medicines committee recommends marketing approval for Pfizer & BioNTech’s Omicron KP.2-adapted Covid-19 vaccine
EMA’s human medicines committee recommends marketing approval for Pfizer & BioNTech’s Omicron KP.2-adapted Covid-19 vaccine: New York Monday, September 23, 2024, 10:00 Hrs [IS ...
Pharmabiz5h
US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration
US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration: Cambridge, UK Monday, September 23, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science- ...
Pharmabiz6h
Indian pharma working to transition from ‘Inspection Readiness’ to ‘Perpetual Regulatory Readiness’
Indian pharma is working to transition from ‘Inspection Readiness’ to ‘Perpetual Regulatory Readiness’. This is at a time when several US FDA observations on regulatory compliance to highlight areas ...
Pharmabiz6h
DCC recommends amendment of rules to regulate sale of antimicrobials to non-pharma industries
DCC recommends amendment of rules to regulate sale of antimicrobials to non-pharma industries: Gireesh Babu, New Delhi Monday, September 23, 2024, 08:00 Hrs [IST] The Drugs Consul ...
Pharmabiz1d
Acelyrin to present positive results from global phase 3 trial of izokibep in hidradenitis suppurativa at EADV 2024
Acelyrin to present positive results from global phase 3 trial of izokibep in hidradenitis suppurativa at EADV 2024: Los Angeles Saturday, September 21, 2024, 18:00 Hrs [IST] Acel ...